SARA ECKERT: Open Payments
NPI 1073759940 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 41 payments from 23 companies in 2025. Trend: 2023 $238 · 2024 $507 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $227 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| Astellas Pharma US Inc | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Cumberland Pharmaceuticals, Inc. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Genmab U.S., Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| PFIZER INC. | 2 | $45 |
| Incyte Corporation | 1 | $30 |
Products named: RYBREVANT, Xtandi, LIBTAYO, SANCUSO, CARVYKTI, KISQALI, TECVAYLI, Padcev.
Industry payments across KY — which companies pay providers there.
